Sommaire

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A5

    
• • ·Information for Readers

    Page :A6

    

• Editorials

  • ·Do heart failure trials need an end point committee?

    Page :571-573

    Jalal K. Ghali

    Plan Plan
  • ·The role of the electrocardiogram as a prognostic tool in ST-segment elevation myocardial infarction

    Page :574-576

    Eric R. Bates

    Plan Plan

• Curriculum in Cardiology

  • ·Dronedarone and vitamin K antagonists: A review of drug-drug interactions

    Page :577-582

    Shailesh C. Shirolkar, Mona Fiuzat, Richard C. Becker

    Résumé Résumé Plan Plan  

• Progress in Cardiology

  • ·Novel biomarkers in cardiovascular disease: Update 2010

    Page :583-594

    Willibald Hochholzer, David A. Morrow, Robert P. Giugliano

    Résumé Résumé Plan Plan  
  • ·Novel antiplatelet therapy

    Page :595-604

    Michael A. Gaglia, Steven V. Manoukian, Ron Waksman

    Résumé Résumé Plan Plan  

• Results of Expert Meetings

  • ·Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies

    Page :605

    Melissa H. Kong, Eric D. Peterson, Gregg C. Fonarow, Gillian D. Sanders, Clyde W. Yancy, Andrea M. Russo, Anne B. Curtis, Samuel F. Sears, Kevin L. Thomas, Susan Campbell, Mark D. Carlson, Chris Chiames, Nakela L. Cook, David L. Hayes, Michelle LaRue, Adrian F. Hernandez, Edward L. Lyons, Sana M. Al-Khatib

    Résumé Résumé Plan Plan  

• Cardiac Safety Research Consortium

  • ·Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: A Cardiac Safety Research Consortium “Incubator” Think Tank

    Page :619

    Sana M. Al-Khatib, Hugh Calkins, Benjamin C. Eloff, Peter Kowey, Stephen C. Hammill, Kenneth A. Ellenbogen, Danica Marinac-Dabic, Albert L. Waldo, Ralph G. Brindis, David J. Wilbur, Warren M. Jackman, Marcia S. Yaross, Andrea M. Russo, Eric Prystowsky, Paul D. Varosy, Thomas Gross, Ellen Pinnow, Mintu P. Turakhia, Mitchell W. Krucoff

    Résumé Résumé Plan Plan  
  • ·Electrocardiographic assessment for therapeutic proteins—scientific discussion

    Page :627-634

    Ignacio Rodriguez, Andrew Erdman, Desmond Padhi, Christine E. Garnett, Hong Zhao, Shari L. Targum, Suchitra Balakrishnan, Colette Strnadova, Norman Viner, Mary Jane Geiger, Christopher Newton-Cheh, Jeffrey Litwin, Michael K. Pugsley, Philip T. Sager, Mitchell W. Krucoff, John K. Finkle

    Résumé Résumé Plan Plan  

• Trial Design

  • ·Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)

    Page :635

    Christian T. Ruff, Robert P. Giugliano, Elliott M. Antman, Sharon E. Crugnale, Tomas Bocanegra, Michele Mercuri, James Hanyok, Indravadan Patel, Minggao Shi, Dan Salazar, Carolyn H. McCabe, Eugene Braunwald

    Résumé Résumé Plan Plan  
  • ·Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial

    Page :642

    Farzin Beygui, Eric Vicaut, Patrick Ecollan, Jacques Machecourt, Eric Van Belle, Faiez Zannad, Gilles Montalescot

    Résumé Résumé Plan Plan  
  • ·Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (?-Blocker Evaluation of Survival Trial [BEST])

    Page :649-654

    Peter Carson, Mona Fiuzat, Christopher O'Connor, Inder Anand, Jonathan Plehn, Jo Ann Lindenfeld, Marc Silver, Michel White, Alan Miller, Gordon Davis, Alastair D. Robertson, Michael Bristow, Stephen Gottlieb

    Résumé Résumé Plan Plan
  • ·Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease

    Page :655

    Harvey White, Claes Held, Ralph Stewart, David Watson, Robert Harrington, Andrzej Budaj, Ph. Gabriel Steg, Christopher P. Cannon, Susan Krug-Gourley, Janet Wittes, Trupti Trivedi, Elizabeth Tarka, Lars Wallentin

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences

    Page :662-670

    Marzia Lotrionte, Giuseppe Biondi-Zoccai, Massimo Imazio, Davide Castagno, Claudio Moretti, Antonio Abbate, Pierfrancesco Agostoni, Antonio L. Brucato, Pietro Di Pasquale, Marja Raatikka, Giuseppe Sangiorgi, Antonio Laudito, Imad Sheiban, Fiorenzo Gaita

    Résumé Résumé Plan Plan  
  • ·Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial

    Page :671-677

    Mustafa Toma, Yuling Fu, Justin A. Ezekowitz, Finlay A. McAlister, Cynthia M. Westerhout, Christopher B. Granger, Paul W. Armstrong

    Résumé Résumé Plan Plan  
  • ·Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: Insights from the GUSTO-III trial

    Page :678-684

    Andrea H. Tackett, Alison L. Bailey, Joanne Micale Foody, Julie M. Miller, Carolyn Apperson-Hansen, E. Magnus Ohman, Judith S. Hochman, Sharon L. Karnash, Robert M. Califf, Eric J. Topol, David J. Moliterno

    Résumé Résumé Plan Plan
  • ·Increase in tissue and circulating pentraxin3 levels in patients with aortic valve stenosis

    Page :685-691

    Yoshiro Naito, Takeshi Tsujino, Hirokuni Akahori, Mitsumasa Ohyanagi, Masataka Mitsuno, Yuji Miyamoto, Hiroyuki Hao, Seiichi Hirota, Tohru Masuyama

    Résumé Résumé Plan Plan  
  • ·Impact of prenatal diagnosis and anatomical subtype on outcome in double outlet right ventricle

    Page :692-700

    Maria E. Lagopoulos, Cedric Manlhiot, Brian W. McCrindle, Edgar T. Jaeggi, Mark K. Friedberg, Lynne E. Nield

    Résumé Résumé Plan Plan  
  • ·Are changes in carotid intima-media thickness related to risk of nonfatal myocardial infarction? A critical review and meta-regression analysis

    Page :701-714

    Zachary D. Goldberger, Javier A. Valle, Vineet K. Dandekar, Paul S. Chan, Dennis T. Ko, Brahmajee K. Nallamothu

    Résumé Résumé Plan Plan  
  • ·Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease

    Page :715-720

    Abigail May Khan, Lisa Sullivan, Elizabeth McCabe, Daniel Levy, Ramachandran S. Vasan, Thomas J. Wang

    Résumé Résumé Plan Plan
  • ·Association of ST2 levels with cardiac structure and function and mortality in outpatients

    Page :721-728

    Lori B. Daniels, Paul Clopton, Navaid Iqbal, Kimberly Tran, Alan S. Maisel

    Résumé Résumé Plan Plan  
  • ·Longitudinal mechanics of the periinfarct zone and ventricular tachycardia inducibility in patients with chronic ischemic cardiomyopathy

    Page :729-736

    Matteo Bertini, Arnold C.T. Ng, C. Jan Willem Borleffs, Victoria Delgado, Adrianus P. Wijnmaalen, Gaetano Nucifora, See H. Ewe, Miriam Shanks, Joep Thijssen, Katja Zeppenfeld, Mauro Biffi, Dominic Y. Leung, Martin J. Schalij, Jeroen J. Bax

    Résumé Résumé Plan Plan  
  • ·Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy

    Page :737-743

    Dominique Auger, Rutger J. van Bommel, Matteo Bertini, Victoria Delgado, Arnold C.T. Ng, See Hooi Ewe, Miriam Shanks, Nina Ajmone Marsan, Eline A.Q. Mooyaart, Tomasz Witkowski, Don Poldermans, Martin J. Schalij, Jeroen J. Bax

    Résumé Résumé Plan Plan  
  • ·Racial differences in long-term survival among patients with coronary artery disease

    Page :744-751

    Kevin L. Thomas, Emily Honeycutt, Linda K. Shaw, Eric D. Peterson

    Résumé Résumé Plan Plan  
  • ·Impact of hospitalization on health-related quality of life in atrial fibrillation patients in Canada and the United States: Results from an observational registry

    Page :752-758

    Matthew R. Reynolds, Edith Morais, Peter Zimetbaum

    Résumé Résumé Plan Plan  
  • ·Efficacy and safety of fenofibric acid in combination with atorvastatin and ezetimibe in patients with mixed dyslipidemia

    Page :759-766

    Peter H. Jones, Anne C. Goldberg, Howard R. Knapp, Maureen T. Kelly, Carolyn M. Setze, James C. Stolzenbach, Darryl J. Sleep

    Résumé Résumé Plan Plan  
  • ·Rapid adoption of drug-eluting stents: Clinical practices and outcomes from the early drug-eluting stent era

    Page :767

    John J. Lopez, Michelle J. Keyes, Sandeep Nathan, Robert Piana, Michael Pencina, Gaurav Dhar, Steven Marso, Sunil Rao, Salim Shammo, Walt Marquardt, David J. Cohen, Neal S. Kleiman

    Résumé Résumé Plan Plan  
  • ·Serial angiographic findings and prognosis of stent fracture site without early restenosis after sirolimus-eluting stent implantation

    Page :775.e1

    Yasushi Ino, Yasuaki Toyoda, Atsushi Tanaka, Shuuta Ishii, Yoshio Kusuyama, Takashi Kubo, Shigeho Takarada, Hironori Kitabata, Takashi Tanimoto, Kumiko Hirata, Masato Mizukoshi, Toshio Imanishi, Takashi Akasaka

    Résumé Résumé Plan Plan  
  • ·Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure

    Page :776-783

    Paolo G. Rusconi, David A. Ludwig, Christopher Ratnasamy, Robert Mas, William G. Harmon, Steven D. Colan, Steven E. Lipshultz

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Is screening cardiac inpatients for depression really feasible?

    Page :e29

    Mehrul Hasnain, W. Victor R. Vieweg

    
  • ·Is screening cardiac inpatients for depression really feasible?

    Page :e31

    Gillian Sowden, Jeff C. Huffman

    
  • ·Unified definition of clinical trials end points

    Page :e33

    Jalal K. Ghali